IntegraGen, Inc. will commercialize company’s molecular tests.

IntegraGen SA established IntegraGen, Inc., as a wholly owned U.S. subsidiary, based in New York. Robert Gottlieb was named CEO. “With the incorporation of IntegraGen Inc., the IntegraGen Group has made a significant step forward, which allows the Group to effectively market its genetic testing services into this important market,” remarks Jan Mous, Ph.D., president and CEO of IntegraGen SA.

IntegraGen has two commercial operations. Diagnostic testing and counselling services are offered through a Diabetes Competence Center, based in Bonn, Germany. A Genetic Services business, operating out of the company’s headquarters in Evry, France, provides customized genotyping and BAC array services.

The company is currently focused on type 2 diabetes, obesity, autism, and bipolar disorder. Clinical trials for the company’s first genetic test for autism, based on internally identified genes, are planned for the first quarter of 2007.

Previous articleSchering-Plough Shells Out $111M for Hep B Drug
Next articleForest Buys Antibiotics Firm in Deal Worth $494M